Home Your basket
• "Sonorous man" - an appro...
   Price 8.50 €
• Interventional phoniatry...
   Price 14.00 €
• Treatment of children wit...
   Price 8.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Radiofrequency inferior t...
   Price 14.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Study on the modeling of ...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• Recent advances in surger...
   Price 5.50 €
• The European Evaluation o...
   Price 8.50 €
• Vascular tumors of the n...
   Price 10.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• The outcome of treatments...
   Price 10.50 €
• Difficult blepharoplastie...
   Price 10.50 €
• Voice after supracricoid ...
   Price 10.50 €
• Congenital absence of the...
   Price 8.50 €
• Giant metastasis invading...
   Price 5.50 €
• Sinonasal hemangiopericyt...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• Botulinum toxin in the lo...
   Price 14.00 €
• Context influence on the ...
   Price 10.50 €
• Otomycosis due to Scopula...
   Price 10.50 €
• Treatment of head and nec...
   Price 10.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• Head and neck reconstruct...
   Price 10.50 €
• Chondrosarcoma of the hyo...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Vibrant Soundbridge for h...
   Price 10.50 €
• Rehabilitation strategies...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €

Total Order 301.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2002 o

RHINOLOGY

Pleomorphic adenoma of the nasal cavity: a case arising from the wall of the maxillary sinus.


Authors : F. Facon, J. Paris, S. Ayache, M. A. Chrestian, P. Dessi (Marseille)

Ref. : Rev Laryngol Otol Rhinol. 2002;123,2:103-107.

Article published in french
Downloadable PDF document french



Summary : Introduction: pleomorphic adenoma is a common and benign tumour, originating from sero-mucous glands. Location in the nasal cavity and particularly on the medial wall of the maxillary sinus is very rare. Patients and methods: one patient with a pleomorphic adenoma of the nasal cavity and a review of literature are reported in order to describe the diagnostic and therapeutic management of this tumour. Results: a 63-year-old woman was referred to our institution for evaluation of an unilateral nasal tumour. Clinical and radiological studies revealed an intra-nasal tumour, slightly lytic in nature, arising from the mucosa of the medial wall of the maxillary sinus. More than 2 years after complete excision of the tumour using an endoscopic procedure, the nasal cavity was free of tumour. Discussion: pleomorphic adenoma of the nasal cavity is a rare and benign tumour, usually presenting as a unilateral nasal tumour. Prognosis of this tumour is mainly linked to recurrences in cases of incomplete resection and to possible metastasis, such as an eventual malignant evolution. The gold standard treatment is complete surgical resection. After a complete imaging study for patient selection (CT scan and MRI), endonasal endoscopic surgery seems to be a reliable therapeutic treatment. Conclusion: intra-nasal pleomorphic adenoma originates from nasal seromucous glands. Radiological study reveals a slightly lytic tumour developed from the septum of the medial wall of the maxillary sinus. Resection can be performed with endoscopic endonasal surgery as long as the orbital bony framework and the ethmoidal roof are free of tumour. Whatever technique is employed, long term follow-up has to be used to detect any recurrence.


Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE